A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer (BIONIKK)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02960906 |
Recruitment Status :
Completed
First Posted : November 10, 2016
Last Update Posted : April 26, 2021
|
Sponsor:
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Information provided by (Responsible Party):
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | February 15, 2021 |
Actual Study Completion Date : | February 15, 2021 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):